๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus

โœ Scribed by Muhammad A. Abdul-Ghani; Luke Norton; Ralph A. DeFronzo


Book ID
113091617
Publisher
Current Science Inc.
Year
2012
Tongue
English
Weight
224 KB
Volume
12
Category
Article
ISSN
1534-4827

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The SGLT2 Inhibitor Empagliflozin for th
โœ McGill, Janet B. ๐Ÿ“‚ Article ๐Ÿ“… 2014 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 617 KB

## Introduction The treatment of type 2 diabetes mellitus (T2DM) continues to pose challenges for clinicians and patients. The dramatic rise in T2DM prevalence, which has paralleled the rise in obesity, has strained the healthcare system and prompted the search for therapies that not only effective